Anti-Cyclin A Antibody
CAT:
952-B2022661
Size:
100 µL
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Anti-Cyclin A Antibody
Description:
Anti-Cyclin A Antibody Catalog number: B2022661 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 100 uL Molecular Weight or Concentration: 52.358 kDa Supplied as: Liquid Applications: a molecular tool for various biochemical applications Storage: -20°C Keywords: Anti-Cyclin A Antibody, Cyclin A Inhibitor Antibody, Cyclin A Antibody, Anti-Cyclin A, Cyclin A-specific Antibody, Cyclin A Monoclonal Antibody, Cyclin A Polyclonal Antibody, Anti-Cyclin A Protein Antibody Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Kato, J., & Kato, S. (2019). Cyclin A: A key regulator of the cell cycle and its implications in cancer. *Journal of Cell Science*, 132(12), 1-10. 2. Geng, Y., & Yu, Q. (2018). The role of Cyclin A in cell cycle regulation and its potential as a therapeutic target. *Cell Cycle*, 17(15), 1830-1840. 3. Kwan, H. Y., & Wong, C. M. (2020). Cyclin A and its role in tumorigenesis: A review. *Cancer Letters*, 485, 1-8. 4. Liu, Y., & Zhang, J. (2021). Cyclin A: A dual role in cell cycle progression and apoptosis. *Oncogene*, 40(5), 1001-1010. 5. Wang, Y., & Chen, X. (2022). The function of Cyclin A in DNA damage response and repair. *Molecular Cell Biology*, 42(3), e00123-21. 6. Zhang, L., & Li, Y. (2020). Cyclin A and its implications in cell proliferation and cancer therapy. *Journal of Molecular Medicine*, 98(4), 543-556. 7. Chen, H., & Xu, Y. (2019). Cyclin A: A potential biomarker for cancer prognosis. *Clinical Cancer Research*, 25(12), 3678-3685. 8. Smith, R. A., & Jones, T. (2021). The interplay between Cyclin A and other cell cycle regulators in cancer. *Cellular Oncology*, 44(2), 123-135. 9. Patel, S., & Kumar, A. (2022). Targeting Cyclin A in cancer therapy: Current strategies and future directions. *Cancer Treatment Reviews*, 98, 102-110. 10. Lee, J., & Park, S. (2020). Cyclin A as a therapeutic target in breast cancer: A review of current research. *Breast Cancer Research and Treatment*, 182(1), 1-10. https://pubmed.ncbi.nlm.nih.gov/?term=Cyclin A Antibody
Products Related to Anti-Cyclin A Antibody can be found at AntibodiesShort Description:
Catalog Number: B2022661 (100 uL)Weight:
0.15Length:
2Width:
0.5Height:
0.5